To view this email as a web page, click here.

Timing of Palliative Care Linked to Better Lung Cancer Survival

The study found patients with lung cancer referred to palliative care earlier lived longer.

Study Finds High Number of European Cancer Drug Trials at Risk for Bias

Half of the cancer drug trials that led to approvals by the European Medicines Agency may have been associated with a high risk for bias.

IN CASE YOU MISSED IT

Delays in CAR T-Cell Treatment Cost Patients, Society

Delays in CAR T-cell therapy may significantly decrease gains in survival and productivity for patients with diffuse large B-cell lymphoma and pediatric acute lymphoblastic leukemia.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.